Table 3 Toxicities by grade and causality in the newly diagnosed GBM patients treated with combined TTFields-Temozolomide.

Elevated LFTs

6/10

0/10

Anti Epileptic Drugs

Hyperglycemia

4/10

0/10

Oral Steroids

Anemia

6/10

0/10

Temozolomide

Thrombocytopenia

2/10

0/10

Temozolomide

Leucopenia

3/10

0/10

Temozolomide

Headache

2/10

0/10

Underlying disease

Seizures

1/10

0/10

Underlying disease

Dermatitis

10/10

0/10

NovoTTF-100A